Document is current

Any future updates will be listed below

Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells

Crossref DOI link: https://doi.org/10.1186/s12951-017-0325-y

Published Online: 2018-01-13

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark